Concepedia

P.N. Munster

PM

Statistics

Publications

12

Citations

739

H-Index

12

Active since

2006

Affiliations

Moffitt Cancer Center(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

Sarah Cannon

Cornell University

The University of Texas MD Anderson Cancer Center

P.N. Munster is an author at Moffitt Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

2006–2019

12

Publications

12

A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors

Renata Ferrarotto, Gail Eckhardt, Akash Patnaik et al. · Annals of Oncology · 2018 · 136 citations · Full text

, , +17

Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy

Mario Campone, Igor Bondarenko, Stephen Brincat et al. · Annals of Oncology · 2011 · 104 citations · Full text

, , +17

Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours

Sarina A. Piha‐Paul, P.N. Munster, Antoine Hollebecque et al. · European Journal of Cancer · 2015 · 75 citations

, , +6

Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer

Joseph A. Sparano, Stacy L. Moulder, Aslamuzzaman Kazi et al. · Clinical Cancer Research · 2009 · 74 citations · Full text

, , +17

Targeted Inhibition of Farnesyltransferase in Locally Advanced Breast Cancer: A Phase I and II Trial of Tipifarnib Plus Dose-Dense Doxorubicin and Cyclophosphamide

Joseph A. Sparano, Stacy L. Moulder, Aslamuzzaman Kazi et al. · Journal of Clinical Oncology · 2006 · 66 citations · Full text

, , +17

1–5 of 12